Financials
- Fiscal year
- 2025
- Total assets
- €1,072
- Loss
- -€23,338
- Solvency
- -18165.4%
Total assets▼ 93.6%
Net result
20202025
LIFE SOLUTIONS
ActiveSummary
LIFE SOLUTIONS has been active since 2019 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show negative equity (-€194,664) and a net result of -€23,338. Equity is shrinking by ~12.4% per year across the filed fiscal years. Its solvency ranks better than 5% of 21069 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 1.3% (low).
Overview
Activity
Retail sale of medical and orthopaedic goods, excluding prescription glasses and lenses
NACE 47741NACE 47740
1 site
Size
€1,072total assets 2025
- Equity
- -€194,664
- Loss
- -€23,338
Turnover not published (abridged schema)
Structure
- Largest shareholder
- SILYMASEMA · 50%
Accounts 44 d early0 of 1 deed read
Why 53Capped at 59: negative equity- Negative equity -€194,664- Loss of €23,338, the second in a row (FY 2025)+ Size: total assets €1,072+ Liquidity: current ratio 0.26, cash €371, halvedShow the evidence
Checked score
Score 2025
53
/ 100
Fair
Probability in this band: 1.5% to 4.2%
Better than 19% of its sector peers (NACE 47, micro)
Performance against the sector, not lower risk
Negative equity caps the score at 59. Every signal that weighs is under Signals.
Financial strength · tick = 2024
Weak
Solvency
0=
equity -18165.4% of total assets
Liquidity
43-14
short-term debt 359.2% · cash 34.7%
Profitability
0=
return on assets -2177.8%
Bankruptcy probability, 12 months
1.3%
Low
0%0.5%1.5%4%10%≥ 25%
About 1 in 100 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
11-2024: 0.6%lowest value
12-2024: 0.7%▲ +5.5% vs 11-2024
01-2025: 0.7%▲ +4.0% vs 12-2024
02-2025: 1.4%▲ +105% vs 01-2025
03-2025: 1.4%● 0.0% vs 02-2025
04-2025: 1.4%▲ +0.6% vs 03-2025
05-2025: 1.5%▲ +2.5% vs 04-2025
06-2025: 1.5%● 0.0% vs 05-2025
07-2025: 1.5%▲ +2.0% vs 06-2025
08-2025: 1.5%● 0.0% vs 07-2025
09-2025: 1.5%▼ -0.8% vs 08-2025
10-2025: 1.5%▲ +2.7% vs 09-2025highest value
11-2025: 1.5%▼ -3.7% vs 10-2025
12-2025: 1.4%▼ -3.3% vs 11-2025
01-2026: 1.3%▼ -11.9% vs 12-2025
02-2026: 1.3%● 0.0% vs 01-2026
03-2026: 1.3%● 0.0% vs 02-2026
04-2026: 1.3%● 0.0% vs 03-2026
05-2026: 1.3%● 0.0% vs 04-2026
06-2026: 1.3%● 0.0% vs 05-2026
07-2026: 1.2%▼ -1.6% vs 06-2026
08-2026: 1.2%● 0.0% vs 07-2026
09-2026: 1.2%● 0.0% vs 08-2026
10-2026: 1.3%▲ +1.5% vs 09-2026
- Size: total assets €1,072 lowers the probability for this profile
- Negative equity -€194,664 raises the probability
- Liquidity: current ratio 0.26, cash €371, halved lowers the probability
- Loss of €23,338, the second in a row (FY 2025) raises the probability
No credit on open account
balance sheet total too small for a liquidity verdict, and equity is negative.
How it is calculated
The band comes from the bankruptcy probability on a scale of 0 to 100: every 10 points more double the odds of getting through the year without bankruptcy.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Place inside the band: half the bankruptcy probability, half how the company does against its sector peers (NACE 47, micro). Better than this share of them on solvency 6%, liquidity 42%, profitability 6%, growth against the median 23%. That is performance, not lower risk; the band itself always comes from the probability.
Bankruptcy probability: model pd-v3.202610021621, computed on 03-10-2026. The model learns from Belgian bankruptcies and reads the registers, the annual accounts and the gazette.
Ceilings: negative or zero equity, a heavy loss, a special KBO legal situation and a missing filing 59 (two missing 44), an ongoing judicial reorganisation or an ending 24. Financial strength does not count in the score.
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
Six signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Negative equity
The 2025 annual accounts show negative equity and a net loss.
NBB · annual accounts 2025Equity per financial year
202122232425
2020 to 2025 · latest year -€194,664
neutral · Latest accounts filed on time
The financial year that closed on 30-06-2025 was due by 31-01-2026 and was filed on 18-12-2025, 44 days ahead of the deadline.
NBB · 6 filingsDeviation from the deadline
2025
44 d early
2024
on the day
2023
1 d early
2022
on the day
2021
18 d late
2020
78 d late
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 6 accounts on average 9 days after the deadline; the sector median for financial year 2024 is on the deadline day, and 47% of the sector filed late.
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 30-06-2026 and is due by 31-01-2027. Nothing is late today. Usually files around 31 January (4 of the last 5 filed years within 30 days of that day).
Companies Code · seven monthsPosition in the running window
30-06-2026 close03-10-2026 today31-01-2027 deadline
- Annual accounts filedfiscal year 2025 · micro…
- Annual accounts filedfiscal year 2024 · micro…
- Annual accounts filedfiscal year 2023 · micro…
Key points
- Risk: Negative equityfiscal year 2025: debts exceed assets -€194,664 View
- Caution: Among the weakest 5% on solvencysector median 34.1% · 21,069 companies -18165.4% View
- Caution: 2 loss-making years in a rowloss fiscal year 2025 -€23,338 View
- Positive: Always filed on timeaccounts within the deadline every year 4 years View
By topic
Board & ownership
- Largest shareholder
- SILYMASEMA · 50%
Timeline
- Events
- 8
- Since
- 2021
- Next accounts
- by 31-01-2027
- 18-12-2025Annual accounts filed
- 31-01-2025Annual accounts filed
- 30-01-2024Annual accounts filed
Company details
- Sites
- 1
- Legal form
- Private limited company
- Activity
- Retail sale of medical and orthopaedic goods, excluding…NACE 47741
- Founded
- 11-06-2019
- Year ends
- 30-06
- Peppol
- Reachable for e-invoices
Go further with this company
How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed
Your own company? See how customers, suppliers and banks see it and what to improve first.
Investigating this company? Keep it with today's facts in a case file.